Strzadala, L.; Fiedorowicz, A.; Wysokinska, E.; Ziolo, E.; Grudzień, M.; Jelen, M.; Pluta, K.; Morak-Mlodawska, B.; Zimecki, M.; Kalas, W. An Anti-Inflammatory Azaphenothiazine Inhibits Interferon β Expression and CXCL10 Production in KERTr Cells. Molecules2018, 23, 2443.
Strzadala, L.; Fiedorowicz, A.; Wysokinska, E.; Ziolo, E.; Grudzień, M.; Jelen, M.; Pluta, K.; Morak-Mlodawska, B.; Zimecki, M.; Kalas, W. An Anti-Inflammatory Azaphenothiazine Inhibits Interferon β Expression and CXCL10 Production in KERTr Cells. Molecules 2018, 23, 2443.
Strzadala, L.; Fiedorowicz, A.; Wysokinska, E.; Ziolo, E.; Grudzień, M.; Jelen, M.; Pluta, K.; Morak-Mlodawska, B.; Zimecki, M.; Kalas, W. An Anti-Inflammatory Azaphenothiazine Inhibits Interferon β Expression and CXCL10 Production in KERTr Cells. Molecules2018, 23, 2443.
Strzadala, L.; Fiedorowicz, A.; Wysokinska, E.; Ziolo, E.; Grudzień, M.; Jelen, M.; Pluta, K.; Morak-Mlodawska, B.; Zimecki, M.; Kalas, W. An Anti-Inflammatory Azaphenothiazine Inhibits Interferon β Expression and CXCL10 Production in KERTr Cells. Molecules 2018, 23, 2443.
Abstract
An azaphenothiazine derivative, 6-chloroethylureidoethyldiquino[3,2-b;2’,3’-e][1,4]thiazine (DQT) has recently been shown to exhibit immunosuppressive activities in mouse models. It also inhibited the expression of CXCL10 at the protein level, at non-toxic concentrations, in the culture of KERTr cells treated with double-stranded RNA, poly(I:C). In this report, we demonstrated that DQT inhibits the transcription of the CXCL10 gene. Although CXCL10 is an IFNγ-inducible protein, we found that the CXCL10 protein was induced without the detectable release of IFNγ or IκB degradation. Hence, we concluded that IFNγ or NFκB were not involved in the regulation of the CXCL10 gene in KERTr cells transfected with poly(I:C) as well as in the inhibitory activity of DQT. On the other hand, we found that IFNβ was induced under the same conditions and its expression was inhibited by DQT. Kinetic analysis showed that an increase in IFNβ concentrations occurred 4-8 h after poly(I:C) treatment, while the concentration of CXCL10 was undetectable at that time and started to increase later, when IFNβ reached high levels. Therefore, DQT may be regarded as a new promising inhibitor of IFNβ expression and IFNβ-dependent downstream genes and proteins, e.g., CXCL10 chemokine, which is implicated in pathogenesis of autoimmune diseases.
Biology and Life Sciences, Immunology and Microbiology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.